Synopsis Venous thromboembolism is a cause of morbidity and mortality in trauma patients. The aim of the present study was to evaluate whether a weight-adjusted enoxaparin prophylaxis regimen would reduce the frequency of venous thromboembolism in hospitalized trauma patients. This week’s “MED FACT” discusses a clinical trial from Surgery, “ Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: A double-blind, randomized, pilot study”. Authors: Annika Bickford Kay et.
al. Key Takeaways Weight-based enoxaparin dosing for venous thromboembolism chemoprophylaxis provides better protection against venous thromboembolism. Objective: To evaluate whether a weight-adjusted enoxaparin prophylaxis regimen would reduce the frequency of venous thromboembolism Study Type: Prospective, randomized pilot study Participants: 234 What Was The Need For This Study? Venous…
